Images List Premium Download Classic

Enzyme Inhibitor

Enzyme Inhibitor-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Aminoester derivatives
Chiesi Farmaceutici S.p.a.
January 18, 2018 - N°20180016265

Compounds of formula (i) are both phosphodiesterase 4 (pde4) enzyme inhibitors and muscarinic m3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
Avanir Pharmaceuticals, Inc.
December 14, 2017 - N°20170354652

During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages. Improved motor control has been exemplified to date by improved ability to swallow and/or speak, among victims of stroke, head ...
Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
Avanir Pharmaceuticals, Inc.
December 07, 2017 - N°20170348301

During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages. Improved motor control has been exemplified to date by improved ability to swallow and/or speak, among victims of stroke, head ...
Enzyme Inhibitor Patent Pack
Download + patent application PDFs
Enzyme Inhibitor Patent Applications
Download + Enzyme Inhibitor-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Enzyme Inhibitor-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Aminoester derivatives
Chiesi Farmaceutici S.p.a.
November 30, 2017 - N°20170340616

Compounds of formula (i), defined herein, are both phosphodiesterase 4 (pde4) enzyme inhibitors and muscarinic m3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract.
Hbv rnase h purification and enzyme inhibitors
Saint Louis University
November 23, 2017 - N°20170335296

Provided herein are methods for the obtention of an active hbv rnaseh preparation and its use in screening methods to identify potential inhibitors of the enzyme for possible use as therapeutic agents. Also provided are methods of treatment using agents identified according to the screen.
Administration of ubiquitin-activating enzyme inhibitor and radiation
Millennium Pharmaceuticals, Inc.
November 23, 2017 - N°20170333434

Disclosed are methods for the treatment of cancer in patients in need of such treatment. The methods comprise administering to such a patient an ubiquitin-activating enzyme (uae) inhibitor such as ((1r,2r,3s,4r)-2,3-dihydroxy-4-(2-(3-(trifluoromethylthio) phenyl)pyrazolo[1,5-a]pyrimidin-7-ylamino)cyclopentyl)methyl sulfamate (compound 1) or a pharmaceutically acceptable salt in combination with radiation. Also disclosed ...
Enzyme Inhibitor Patent Pack
Download + patent application PDFs
Enzyme Inhibitor Patent Applications
Download + Enzyme Inhibitor-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Enzyme Inhibitor-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Apparatus and method for addition of adh enzyme inhibitors to existing engine cooling systems
November 16, 2017 - N°20170327721

An apparatus and method for the addition of alcohol dehydrogenase (adh) enzyme inhibitors to existing engine cooling systems to reduce or eliminate the coolant toxicity without the need to completely drain and replace the entire engine coolant. In addition, the present invention provides an apparatus and method for treatment of otherwise toxic coolants removed from engine cooling systems that are ...
Adenylation enzyme inhibitors
Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis
November 16, 2017 - N°20170327549

The present invention concerns compounds that are capable of covalently entrapping adenylating enzymes. The present invention is essentially based on the discovery that analogues of adenylating enzyme (ae) substrates, wherein a methylene group has been incorporated at the carbon atom in the α-position relative to the carboxylate group involved in the adenylation, are capable of undergoing the adenylation ...
Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
Academia Sinica
October 05, 2017 - N°20170283878

The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid ssea-3/ssea-4/globoh in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4galt; beta-4galnact-i; or beta-3galt-v ...
Herbicide-tolerant plants
Basf Agrochemical Products, B.v.
September 28, 2017 - N°20170275645

The present invention provides herbicide-tolerant plants. The present invention also provides methods for controlling the growth of weeds by applying an herbicide to which herbicide-tolerant plants of the invention are tolerant. Plants of the invention may express an acetyl-coenzyme a carboxylase enzyme that is tolerant to the action of acetyl-coenzyme a carboxylase enzyme inhibitors.
Hgh determination for use to guide prevention of a major adverse cardiac event or a ...
Sphingotec Gmbh
August 17, 2017 - N°20170234889

A method of determining whether a subject has a vascular risk that can be reduced by blood pressure lowering therapy with antihypertensive drugs (e. G. Angiotensin converting enzyme inhibitor (ace inhibitor), angiotensin receptor blocker (arb), beta-adrenoreceptor blocker (beta-blocker) and/or statins) by determining the level of hgh, and/or its isoforms in a blood sample of said subject and comparing ...
Metalloenzyme inhibitor compounds as fungicides
Dow Agrosciences Llc
August 17, 2017 - N°20170233369

The instant invention describes compounds of formula i having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Detoxifying and recycling of washing solution used in pretreatment of lignocellulose-containing materials
Cofco Ltd
August 10, 2017 - N°20170226694

The invention relates to a process of detoxifying pretreated lignocellulose-containing material comprising washing the pretreated lignocellulose-containing material in a washing solution and treating the used washing solution to remove an enzyme inhibitor and/or an inhibitor of a fermenting organism before recycling the used washing solution.
Enzyme Inhibitor Patent Pack
Download + patent application PDFs
Enzyme Inhibitor Patent Applications
Download + Enzyme Inhibitor-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Enzyme Inhibitor-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Metalloenzyme inhibitor compounds
May 25, 2017 - N°20170143694

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Cinnamomum burmanii extract, extraction process and its use as proton pump down-regulator, enzyme inhibitor, and ...
Pt. Dexa Medica
May 11, 2017 - N°20170128513

Extract and/or fraction from cinnamomum burmanii (dlbs2411) related to its extraction method and its biological activities show activities as antiulcer by conferring mucoprotection and down-regulating h+/kt+ atpase. Treatment with dlbs2411 decreases the h+/k+ atpase mrna level in hek 293 and gastric parietal cells. In addition, dlbs2411 inhibits activity of h+/k+ atpase gastric enzyme wherein ph influences this ...
Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
Signature Therapeutics, Inc.
May 04, 2017 - N°20170119754

A method of providing a patient with controlled release of ketone-containing opioid using a prodrug capable, upon enzymatic activation and intramolecular cyclization, of releasing the ketone-containing opioid is disclosed. The disclosure also provides such prodrug compounds and pharmaceutical compositions comprising such compounds. Such pharmaceutical compositions can optionally include an enzyme inhibitor that interacts with the enzyme(s) to mediate the ...
Methods and compositions for regulating conversion of a prodrug to an active pharmaceutical ingredient
Acura Pharmaceuticals, Inc.
April 27, 2017 - N°20170112825

An abuse deterrent pharmaceutical composition including an abuse deterrent pharmaceutical composition including a prodrug of a pharmaceutically active ingredient and an enzyme inhibitor, wherein the enzyme inhibitor retards conversion of the prodrug to the pharmaceutically active ingredient when the composition is ingested in excess of an intended dosage.
Pharmaceutical combination for the treatment of cancer
Piramal Enterprises Limited
April 27, 2017 - N°20170112809

The present invention relates to a pharmaceutical combination comprising a cdk inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a cdk inhibitor and a therapeutically effective amount ...
Urea compounds and their use as enzyme inhibitors
April 13, 2017 - N°20170101381

Or a pharmaceutically acceptable salt or derivative thereof. The compound may be used in the treatment or prevention of a disorder selected from appetite regulation, obesity, metabolic disorders, cachexia, anorexia, pain, inflammation, neurotoxicity, neurotrauma, stroke, multiple sclerosis, spinal cord injury, parkinson's disease, levodopa-induced dyskinesia, huntington's disease, gilles de la tourette's syndrome, tardive dyskinesia, dystonia, amyotrophic lateral sclerosis, alzheimer's disease, epilepsy, ...
Pde9 inhibitors with imidazo triazinone backbone
H. Lundbeck A/s
March 23, 2017 - N°20170081333

This invention is directed to compounds, which are pde9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (i). The present invention further provides a method of treating a subject suffering ...
Hematopoitetic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of ...
The Medical College Of Wisconsin, Inc.
March 23, 2017 - N°20170080055

Methods and compositions comprising hematopoietic growth factor proteins and/or protein analogs thereof and/or combinations thereof and angiotensin converting enzyme inhibitors to treat the acute and long term adverse effects of radiation exposure in subjects who have been or will be exposed to radiation are disclosed.
Loading